Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial

Circulation. 2020 Sep 8;142(10):1018-1020. doi: 10.1161/CIRCULATIONAHA.120.046374. Epub 2020 Sep 8.

¹ Division of Cardiovascular Disease (V.P, G.A., P.A.), University of Alabama at Birmingham.
² Department of Medicine (N.P.), University of Alabama at Birmingham.
³ Cardiovascular Division, University of Minnesota, Minneapolis (R.K.).
⁴ Cardiology Division, Massachusetts General Hospital, Baim Institute for Clinical Research, Boston (J.L.J.).
⁵ Duke Clinical Research Institute, Durham, NC (G.M.F.).
⁶ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (T.J.W.).
⁷ Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).

Abstract

NTproBNP ≤1000 has favorable prognostic implications in HF, but the prognosis is worse for Black patients at any level of achieved NTproBNP

Keywords: biomarker; heart failure; natriuretic peptides; race.